Home

Latest News

12345678910
Sabra Healthcare REIT Stock Gets RS Rating Upgradeinvestors.com
Sabra Healthcare REIT stock now clears the 80 or higher Relative Strength Rating threshold, with a jump from 78 to 82 Monday.
Via Investor's Business Daily · March 31, 2025
Peter Schiff Sounds The Alarm: 'Same Mistake Again' Could Trigger Economic Firestormbenzinga.com
Investors should prepare for a 2008-style crisis.Benzinga warns of potential economic crisis predicted by Peter Schiff in 2008. Tariffs, rising interest rates, misguided Fed policy may cause trouble.
Via Benzinga · March 31, 2025
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Databenzinga.com
Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe type 1 diabetes, toward approval.
Via Benzinga · March 31, 2025
Stryker Stock Gets Relative Strength Rating Liftinvestors.com
In a welcome move, Stryker stock saw its Relative Strength Rating improve to 72 on Monday, up from 69 a day earlier.
Via Investor's Business Daily · March 31, 2025
Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecastbenzinga.com
Corcept's ROSELLA trial met its primary endpoint, showing relacorilant improved progression-free and overall survival in platinum-resistant ovarian cancer.
Via Benzinga · March 31, 2025
P/E Ratio Insights for Herc Holdingsbenzinga.com
Via Benzinga · March 31, 2025
Shell Unusual Options Activitybenzinga.com
Via Benzinga · March 31, 2025
11 Analysts Have This To Say About DocuSignbenzinga.com
Via Benzinga · March 31, 2025
Decoding AbbVie's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · March 31, 2025
A Closer Look at Atlassian's Options Market Dynamicsbenzinga.com
Via Benzinga · March 31, 2025
Beyond The Numbers: 30 Analysts Discuss Snowflake Stockbenzinga.com
Via Benzinga · March 31, 2025
Procter & Gamble Options Trading: A Deep Dive into Market Sentimentbenzinga.com
Via Benzinga · March 31, 2025
The Analyst Verdict: Sea In The Eyes Of 7 Expertsbenzinga.com
Via Benzinga · March 31, 2025
Where Varonis Systems Stands With Analystsbenzinga.com
Via Benzinga · March 31, 2025
What 13 Analyst Ratings Have To Say About Baker Hughesbenzinga.com
Via Benzinga · March 31, 2025
Breaking Down Payoneer Global: 6 Analysts Share Their Viewsbenzinga.com
Via Benzinga · March 31, 2025
Nano-X Imaging (NNOX) Q4 2024 Earnings Call Transcriptfool.com
NNOX earnings call for the period ending December 31, 2024.
Via The Motley Fool · March 31, 2025
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
In today's session, these stocks are experiencing unusual volume.
Via Chartmill · March 31, 2025
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Ratingbenzinga.com
Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.
Via Benzinga · March 31, 2025
Growth Or Value? Allspring's New ETFs Offer Bothbenzinga.com
Allspring Global Investments launched two new actively managed ETFs (AGR, ASLV) to provide investors with access to mispriced stocks and value ideas.
Via Benzinga · March 31, 2025
Tom Lee Sees 'Right Pieces' For A Market Bottom: 'Investors Are A Little Too Scared Heading Into Wednesday'benzinga.com
Investors continue to brace for volatility ahead of U.S. President Donald Trump's tariff announcement this week. Fundstrat's Tom Lee believes bullish traders will get rewarded.
Via Benzinga · March 31, 2025
Why Is Corcept (CORT) Stock Soaring Today
Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 94.9% in the afternoon session after the company announced that its Phase 3 trial (ROSELLA) met its goal of improving progression-free survival and overall survival in treating resistant ovarian cancer with a new therapy (a combination of Relacorilant and Nab-paclitaxel). 
Via StockStory · March 31, 2025
Trump Family Tightens Grip On DeFi Platform World Liberty Financialbenzinga.com
The Trump family has significantly increased its control over World Liberty Financial, a decentralized finance platform still under development.
Via Benzinga · March 31, 2025
Okta's Options Frenzy: What You Need to Knowbenzinga.com
Via Benzinga · March 31, 2025
A Closer Look at Delta Air Lines's Options Market Dynamicsbenzinga.com
Via Benzinga · March 31, 2025
Spotlight on PayPal Holdings: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · March 31, 2025
Here’s The Good News – Stocks Getting Closetalkmarkets.com
Bonds rallied and yields fell not because of inflation and certainly not because of tariffs. It goes back to the growth scare.
Via Talk Markets · March 31, 2025
Congressman Buys Up To $600K In Bitcoin ETF After Selling $1 Million In Goldman Sachs Stock: Committee Assignment Could Be Red Flagbenzinga.com
A Congressman who bought shares of a Bitcoin (CRYPTO: BTC) ETF before President Donald Trump announced an Executi
Via Benzinga · March 31, 2025
Gold Rally Could Gain Momentum With Central Bank Buying And China Allocation, Analyst Saysbenzinga.com
Gold prices exceeded $3,000/oz, with potential to reach $3,500 if investment demand rises. China's insurance sector and central banks may increase gold holdings, while ETF inflows signal growing retail interest. Trade policy uncertainty and a weaker U.S. dollar could further support prices.
Via Benzinga · March 31, 2025
Semiconductor Sector Hit Hard as Hedge Funds Retreat from Techtalkmarkets.com
Hedge funds are rapidly reducing their investments in global technology stocks, particularly in the semiconductor industry.
Via Talk Markets · March 31, 2025
Bulls Have A Lot To Prove In Q2talkmarkets.com
The energy sector has been running the table year-to-date. Interestingly, the price of crude oil hasn’t participated much in this rally with the energy sector.
Via Talk Markets · March 31, 2025
Google's New AI Travel Features Could Drive Major Growth In Search Volume: Analystbenzinga.com
On March 27, Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google introduced several new features across Search, Maps, and Gemini
Via Benzinga · March 31, 2025
FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patientsbenzinga.com
FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma.
Via Benzinga · March 31, 2025
Arm Holdings Reportedly Aims To Capture Half Of The Data Center CPU Market In 2025 – Retail’s Divided As Stock Fallsstocktwits.com
The surge in Arm's data center presence is fueled by the rapid expansion of artificial intelligence, Mohamed Awad, the company’s infrastructure chief, told Reuters.
Via Stocktwits · March 31, 2025
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill · March 31, 2025
Monday's session: top gainers and loserschartmill.com
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 31, 2025
Softs Report - Monday, March 31content/com
FCOJ closed lower and kept the down trends in prices intact. Chart trends are down again on the daily charts.
Via Talk Markets · March 31, 2025
Hut 8 Shares Are Down Today: What's Going On?benzinga.com
Hut 8 Corp. (NASDAQ: HUT) shares are are trading lower Monday potenafter the company announced it is spinning off its Bitcoin mining operations into a new entity, American Bitcoin, in partnership with Eric Trump.
Via Benzinga · March 31, 2025
AMD Powers Oracle Cloud With New Epyc Chips Promising Major Boost In Performancebenzinga.com
AMD announced its fifth-generation EPYC processors power OCI Compute E6 shapes, delivering up to 2x better cost to performance. Stock down 45% in past year.
Via Benzinga · March 31, 2025
What's Going On With NLS Pharmaceutics Shares Monday?benzinga.com
NLS Pharmaceutics shares are trading higher on Monday after the company announced it secured up to $3 million in equity financing.
Via Benzinga · March 31, 2025
Surprise In The Report - Funds Are Banking On It - The Corn & Ethanol Reportcontent/com
May CBOT corn ended 11 cents above session lows as end user value is found.
Via Talk Markets · March 31, 2025
Forge Global Stock Tumbles 12% After Board Approves 1-For-15 Reverse Split — Retail’s Still Hopefulstocktwits.com
Forge Global said the reverse stock split is intended to bring the company into compliance with the minimum bid price requirement for continued listing on the New York Stock Exchange.
Via Stocktwits · March 31, 2025
The FTSE Finish Line - Monday, March 31talkmarkets.com
​​​​​​​UK shares dropped on Monday as U.S. President Donald Trump signaled that his reciprocal tariffs would target all countries, escalating tensions in the global trade war.
Via Talk Markets · March 31, 2025
GlobalFoundries Reportedly Explores Merger With UMC Amid Taiwan Tensions – Retail Opinion Dividedstocktwits.com
According to a report by Nikkie Asia, a merger between GlobalFoundries and UMC would create a larger, U.S.-based semiconductor firm with manufacturing capabilities spanning the U.S., Europe, and Asia.
Via Stocktwits · March 31, 2025
Has Primo Waters Sprung A Leak?talkmarkets.com
Primo Brands Corporation operates as a branded beverage company in North America.
Via Talk Markets · March 31, 2025
Demystifying Microsoft: Insights From 16 Analyst Reviewsbenzinga.com
Via Benzinga · March 31, 2025
UNOS adds two members to its board of directors
UNOS adds two members to its board of directors
Via News Direct · March 31, 2025
Breaking Down Allison Transmission: 4 Analysts Share Their Viewsbenzinga.com
Via Benzinga · March 31, 2025
Beyond The Numbers: 5 Analysts Discuss Weatherford International Stockbenzinga.com
Via Benzinga · March 31, 2025
Deep Dive Into United States Steel Stock: Analyst Perspectives (7 Ratings)benzinga.com
Via Benzinga · March 31, 2025